What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
Peter G. Pappas mostly deals with Internal medicine, Surgery, Mycosis, Fluconazole and Aspergillosis.
The various areas that Peter G. Pappas examines in his Internal medicine study include Gastroenterology and Amphotericin B.
He has researched Amphotericin B in several fields, including Voriconazole and Chemotherapy.
His Surgery research is multidisciplinary, incorporating perspectives in Incidence, Relative risk, Confidence interval, Adverse effect and Placebo.
Peter G. Pappas interconnects Itraconazole, Cryptococcosis and Intensive care medicine in the investigation of issues within Mycosis.
His studies in Aspergillosis integrate themes in fields like Zygomycosis, Organ transplantation and Clinical trial.
His most cited work include:
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3691 citations)
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. (2609 citations)
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. (1566 citations)
What are the main themes of his work throughout his whole career to date?
Peter G. Pappas mostly deals with Internal medicine, Intensive care medicine, Surgery, Immunology and Fluconazole.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Amphotericin B, Voriconazole and Aspergillosis.
His Intensive care medicine study combines topics from a wide range of disciplines, such as Antifungal, Clinical trial and Invasive candidiasis.
His Surgery research includes elements of Adverse effect and Incidence.
His studies deal with areas such as Epidemiology and Acquired immunodeficiency syndrome as well as Immunology.
His Fluconazole study combines topics in areas such as Itraconazole and Fungemia, Mycosis.
He most often published in these fields:
- Internal medicine (37.72%)
- Intensive care medicine (20.42%)
- Surgery (20.76%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (37.72%)
- Intensive care medicine (20.42%)
- Antifungal (9.00%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Intensive care medicine, Antifungal, Blood culture and Adverse effect.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Amphotericin B, Caspofungin and Invasive candidiasis.
His work carried out in the field of Amphotericin B brings together such families of science as Cohort study, Retrospective cohort study, Confidence interval, Cryptococcus gattii and Voriconazole.
As part of the same scientific family, Peter G. Pappas usually focuses on Voriconazole, concentrating on Fluconazole and intersecting with Osteomyelitis and Fungemia.
His Intensive care medicine research focuses on Clinical trial and how it connects with Cancer and Invasive fungal disease.
His Adverse effect study incorporates themes from Meningitis, Arachnoiditis, Randomized controlled trial and SUBA-Itraconazole.
Between 2017 and 2021, his most popular works were:
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
- Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel (75 citations)
- Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial (56 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Internal medicine, Intensive care medicine, Clinical trial, Epidemiology and Severe acute respiratory syndrome coronavirus 2 are his primary areas of study.
His Internal medicine study frequently draws connections to adjacent fields such as Micafungin.
His Micafungin study focuses on Voriconazole, Fluconazole and Amphotericin B.
His study in the field of Health evaluation is also linked to topics like Hematologic tests.
His research in Clinical trial intersects with topics in Log-rank test and Cancer.
His Epidemiology research incorporates themes from Lung transplantation, Transplantation, Incidence, Family medicine and Complication.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
